日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Estrogen-regulated miRs in bone enhance osteoblast differentiation and matrix mineralization

雌激素调控的骨骼miRNA促进成骨细胞分化和基质矿化

Emch, Michael J; Wicik, Zofia; Aspros, Kirsten G M; Vukajlovic, Tanja; Pitel, Kevin S; Narum, Anders K; Weivoda, Megan M; Tang, Xiaojia; Kalari, Krishna R; Turner, Russell T; Iwaniec, Urszula T; Monroe, David G; Subramaniam, Malayannan; Hawse, John R

Disruption of estrogen receptor beta's DNA binding domain impairs its tumor suppressive effects in triple negative breast cancer

雌激素受体β DNA结合域的破坏会削弱其在三阴性乳腺癌中的肿瘤抑制作用

Aspros, Kirsten G M; Emch, Michael J; Wang, Xiyin; Subramaniam, Malayannan; Hinkle, Megan L; Rodman, Esther P B; Goetz, Matthew P; Hawse, John R

Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer

雌激素受体β通过重新利用EZH2来抑制三阴性乳腺癌中的致癌NFκB/p65信号通路

Aspros, Kirsten G M; Carter, Jodi M; Hoskin, Tanya L; Suman, Vera J; Subramaniam, Malayannan; Emch, Michael J; Ye, Zhenqing; Sun, Zhifu; Sinnwell, Jason P; Thompson, Kevin J; Tang, Xiaojia; Rodman, Esther P B; Wang, Xiyin; Nelson, Adam W; Chernukhin, Igor; Hamdan, Feda H; Bruinsma, Elizabeth S; Carroll, Jason S; Fernandez-Zapico, Martin E; Johnsen, Steven A; Kalari, Krishna R; Huang, Haojie; Leon-Ferre, Roberto A; Couch, Fergus J; Ingle, James N; Goetz, Matthew P; Hawse, John R

Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues

使用两种经过验证的单克隆抗体优化雌激素受体β的免疫组织化学检测,证实其在正常和恶性乳腺组织中的表达

John R Hawse, Jodi M Carter, Kirsten G M Aspros, Elizabeth S Bruinsma, Justin W Koepplin, Vivian Negron, Malayannan Subramaniam, James N Ingle, Karen L Rech, Matthew P Goetz

Factors affecting wound ooze in total knee replacement

影响全膝关节置换术后伤口渗液的因素

Butt, U; Ahmad, R; Aspros, D; Bannister, G C